PepGen Announces Positive Preclinical Data for PGN-EDO53, PGN-EDO45 and PGN-EDO44, Three Novel Duchenne Muscular Dystrophy Candidates PepGen, Inc Updated Mon, Nov 14, 2022, 8:00 AM 9 min read ...

PepGen, Inc-PGN-EDO51 exhibited the highest levels of oligonucleotide delivery and exon skipping in a clinical study following a single dose when compared to publicly available clinical data for ...

XeteX celebrates the beginning of a new $20 million facility in Holmen, expanding its production capacity and adding 50 new roles. Skip to main content Skip to main content. You are the owner of ...

Xetex celebrated its 40th anniversary by holding a groundbreaking ceremony. The company plans to build a new state-of-the-art manufacturing facility to meet customer demands and create additional ...

Ephedrine hydrochloride inhibits PGN-induced inflammatory responses by promoting IL-10 production and decreasing proinflammatory cytokine secretion via the PI3K/Akt/GSK3β pathway ...